This article is from the source 'bbc' and was first published or seen on . It last changed over 40 days ago and won't be checked again for changes.

You can find the current article at its original source at http://www.bbc.co.uk/news/health-30988643

The article has changed 7 times. There is an RSS feed of changes available.

Version 0 Version 1
Dementia 'linked' to common over-the-counter drugs Dementia 'linked' to common over-the-counter drugs
(about 10 hours later)
A study has linked commonly used medicines, including over-the-counter treatments for conditions such as insomnia and hay-fever, to dementia.A study has linked commonly used medicines, including over-the-counter treatments for conditions such as insomnia and hay-fever, to dementia.
All of the types of medication in question are drugs that have an "anticholinergic" effect.All of the types of medication in question are drugs that have an "anticholinergic" effect.
Experts say people should not panic or stop taking their medicines.Experts say people should not panic or stop taking their medicines.
In the US study, in the journal JAMA Internal Medicine, higher doses and prolonged use were linked to higher dementia risk in elderly people. In the US study in the journal JAMA Internal Medicine, higher doses and prolonged use were linked to higher dementia risk in elderly people.
Side-effectsSide-effects
All medicines can have side-effects and anticholinergic-type drugs that block a neurotransmitter called acetylcholine are no exception.All medicines can have side-effects and anticholinergic-type drugs that block a neurotransmitter called acetylcholine are no exception.
Patient information leaflets accompanying such drugs warn of the possibility of reduced attention span and memory problems as well as a dry mouth.Patient information leaflets accompanying such drugs warn of the possibility of reduced attention span and memory problems as well as a dry mouth.
But researchers say people should also be aware that they may be linked to a higher risk of developing dementia.But researchers say people should also be aware that they may be linked to a higher risk of developing dementia.
Dr Shelly Gray and colleagues from the University of Washington followed the health of 3,434 people aged 65 and older who had no signs of dementia at the start of the study.Dr Shelly Gray and colleagues from the University of Washington followed the health of 3,434 people aged 65 and older who had no signs of dementia at the start of the study.
They looked at medical and pharmacy records to determine how many of the people had been given a drug with an anticholinergic effect, at what dose and how often and compared this data with subsequent dementia diagnoses over the next decade.They looked at medical and pharmacy records to determine how many of the people had been given a drug with an anticholinergic effect, at what dose and how often and compared this data with subsequent dementia diagnoses over the next decade.
The most commonly used anticholinergic-type drugs were medicines for treating depression, antihistamines for allergies such as hay-fever or to aid sleep/promote drowsiness, and drugs to treat urinary incontinence. Nearly a fifth were drugs that had been bought over-the-counter. The most commonly used anticholinergic-type drugs were medicines for treating depression, antihistamines for allergies such as hay-fever or to aid sleep/promote drowsiness, and drugs to treat urinary incontinence. Nearly a fifth were drugs that had been bought over the counter.
Over the course of the study, 797 of the participants developed dementia.Over the course of the study, 797 of the participants developed dementia.
'Not causal''Not causal'
The study estimated that people taking at least 10 mg/day of doxepin (antidepressant), 4 mg/day of diphenhydramine (a sleep aid), or 5 mg/day of oxybutynin (a urinary incontinence drug) for more than three years would be at greater risk of developing dementia. The study estimated that people taking at least 10 mg/day of doxepin (antidepressant), four mg/day of diphenhydramine (a sleep aid), or five mg/day of oxybutynin (a urinary incontinence drug) for more than three years would be at greater risk of developing dementia.
The researchers say doctors and pharmacists might want to take a precautionary approach and offer different treatments instead. And when there is no alternative, they could give the lowest dose for the shortest time possible.The researchers say doctors and pharmacists might want to take a precautionary approach and offer different treatments instead. And when there is no alternative, they could give the lowest dose for the shortest time possible.
Dr Gray says some of the study participants have agreed to have an autopsy after their death.Dr Gray says some of the study participants have agreed to have an autopsy after their death.
"We will look at the brain pathology and see if we can find a biological mechanism that might explain our results.""We will look at the brain pathology and see if we can find a biological mechanism that might explain our results."
Dr Simon Ridley, head of research at Alzheimer's Research UK said the study was interesting but not definitive - there was, he said, no evidence that these drugs cause dementia. Dr Simon Ridley, head of research at Alzheimer's Research UK, said the study was interesting but not definitive - there was, he said, no evidence that these drugs cause dementia.
And Dr Doug Brown, from the UK's Alzheimer's Society, said: "There have been concerns that regular use by older people of certain medications with anticholinergic effects, such as sleep aids and hay-fever treatments, can increase the risk of dementia in certain circumstances, which this study supports. Dr Doug Brown, from the UK's Alzheimer's Society, said: "There have been concerns that regular use by older people of certain medications with anticholinergic effects, such as sleep aids and hay-fever treatments, can increase the risk of dementia in certain circumstances, which this study supports.
"However, it is still unclear whether this is the case and if so, whether the effects seen are a result of long-term use or several episodes of short-term use. More robust research is needed to understand what the potential dangers are, and if some drugs are more likely to have this effect than others."However, it is still unclear whether this is the case and if so, whether the effects seen are a result of long-term use or several episodes of short-term use. More robust research is needed to understand what the potential dangers are, and if some drugs are more likely to have this effect than others.
"We would encourage doctors and pharmacists to be aware of this potential link and would advise anyone concerned about this to speak to their GP before stopping any medication.""We would encourage doctors and pharmacists to be aware of this potential link and would advise anyone concerned about this to speak to their GP before stopping any medication."
He said the charity was funding more research in this area to better understand any connections between these and other drugs on the development of dementia.He said the charity was funding more research in this area to better understand any connections between these and other drugs on the development of dementia.
The Medicines and Healthcare Products Regulatory Agency, which monitors the safety of medicines in clinical use in the UK, said it would review any new evidence.The Medicines and Healthcare Products Regulatory Agency, which monitors the safety of medicines in clinical use in the UK, said it would review any new evidence.